Yahoo Finance
Yahoo FinanceMay 22
Finance

Yahoo Finance Live Dow, S&P 500, Nasdaq advance as tech stocks gain, investors monitor US-Iran talks

120 min video5 key momentsWatch original
TL;DR

Stock market closed higher across all three majors as bond yields eased, with semiconductor and healthcare leading while mega-cap tech stumbled and major IPOs loom.

Key Insights

1

Broader market participationThe S&P 500 equal-weight index hit a record close, meaning smaller stocks and mid-caps are driving gains—not just the 10 mega-cap AI stocks that have powered 60% of global market gains year-to-date.

2

Lilly dominates obesity marketEli Lilly's phase 3 obesity drug data showed 28-30% weight loss over two years, crushing Novo Nordisk's 15% and signaling a multi-year pharma outperformance cycle after years of underperformance.

3

Yield relief sparked rotationBond yields backed off from 20-year highs above 5% mid-week, which had spooked markets earlier, but the relief sent investors into smaller-cap and value trades instead of mega-cap tech.

4

Mega IPO pipelineOpenAI is reportedly preparing an IPO filing for next week, potentially becoming one of the largest tech debuts ever alongside SpaceX's S-1 filing, which could reshape the S&P 500's composition.

5

Sentiment-spending disconnectConsumer sentiment hit record lows yet retail spending remains resilient, with 60% planning summer travel—the K-shaped economy persists as lower-income earners cut back while affluent consumers spend on experiences.

6

Warsh signals growth-friendly stanceFed chair Kevin Warsh was sworn in invoking Greenspan-era philosophy of not raising rates during productivity-driven expansions, signaling a potential shift toward lower-rate bias despite inflation concerns from multiple Fed members.

Deep Dive

Market momentum masks concentration risk

The Dow closed at its first record high since February, the S&P 500 equal-weight index hit a record, and the NASDAQ Composite gained 2.10% after a volatile week driven by 30-year bond yields spiking above 5%—the highest level in nearly two decades. Early-week turbulence from geopolitical tensions around US-Iran talks and surging yields gave way to relief mid-week as bond yields backed off, triggering a broad rally. Healthcare led sectors up 1.2%, followed by technology, with semiconductor names like Skyworks up 12% and Qualcomm up 11%, though mega-cap semis Nvidia and Broadcom declined. Philip Stray from Morningstar Wealth cautioned that despite the breadth, the market remains dangerously concentrated: just 10 stocks accounted for 60% of global equity market gains year-to-date. He recommended rotating into software companies and cloud hyperscalers like Microsoft that offer AI exposure without the semiconductor trade's vulnerability. The AI narrative shifted from caution to momentum as rates stabilized, suggesting the market is fragile if inflation data disappoints.

Warsh takes helm with growth-friendly philosophy

Kevin Warsh was officially sworn in as Federal Reserve chair in a White House ceremony with Supreme Court Justice Clarence Thomas presiding, with Treasury Secretary Scott Bessant, House Speaker Mike Johnson, and National Economic Council Director Kevin Hasset in attendance. President Trump emphasized Warsh's independence while expressing preference for lower rates to manage federal debt, saying the stock market rally showed approval of the selection. Warsh invoked former chair Greenspan's era philosophy, suggesting reluctance to raise rates during productivity-driven economic expansions—a significant shift from rate-hiking cycles. However, multiple Fed members including Governor Chris Waller expressed concern about sticky inflation from oil price shocks, creating tension between the administration's growth agenda and inflation risks. Warsh signaled a neutral stance for 2026 with neither rate cuts nor hikes expected in the base case, though inflation remains the critical variable. The swearing-in ceremony sent a message about the administration's priority on economic growth over inflation-fighting.

Pharma emerges as rotation target as Lilly crushes obesity market

Healthcare sector rallied 1.2% as Eli Lilly demonstrated clinical dominance in obesity drugs. Lilly's phase 3 data for triple G showed 28-30% weight loss over two years, substantially exceeding Novo Nordisk's semaglutide at 15% and Lilly's own tirzepatide at 22%. UBS biotech researcher Michael Yei called pharma and biotech underowned, citing three catalysts: resolution of drug pricing uncertainty under the Trump administration, a robust innovation pipeline beyond obesity (including cancer treatments), and record M&A activity. Merck, Gilead, and Pfizer joined Lilly as recommended names. Novo Nordisk faces significant headwinds despite its $1.5-2 billion oral pill revenue guidance, with the company guiding revenue and earnings down double digits this year as Lilly's superior injectable options steal market share. Yei framed the sector as entering a multi-year positive performance cycle after years of being a forgotten laggard, with valuations appearing reasonable relative to innovation and earnings growth prospects. Merck led pharmaceutical gains at 5.5% on the day.

Options traders price in volatility ahead of long weekend and major IPOs

Options strategist David Iorio flagged unusual hedging activity suggesting sophisticated investors are pricing in risks the market is ignoring. A massive VIX call spread traded earlier in the week paying 3-3.5 million to make 300 million—a 100x payout potential he called unusual and justified. The S&P 500 is pricing in only 70 basis points of move between now and Tuesday, which Iorio deemed too low given historical precedent and potential Middle East headlines around US-Iran talks. He recommended a Tesla June 5th 250-260 call spread as a proxy to play the rumored June 12 SpaceX IPO, noting Tesla was the only MAG 7 stock with consistent weekly call buying rather than customer selling. All that's needed is a 7% move for 5x return. For Salesforce ahead of Wednesday earnings, he suggested a May 29th call fly strategy (buy 190, sell two 200, buy one 210 for about $1) to profit from the stock's 40% realized volatility and 8.5% implied move, arguing the options are appropriately priced unlike broader market complacency.

OpenAI and SpaceX IPOs reshape the IPO calendar

Reports emerged that OpenAI is preparing to file for an IPO as soon as next week after working with bankers on preparations, potentially representing one of the biggest tech debuts ever given the company's scale and market significance. This announcement comes alongside SpaceX's S-1 filing on Wednesday, setting up a transformational period for the IPO market. David Bull Bay explained that SpaceX's inclusion in the S&P 500 could trigger significant ripple effects through index methodology changes and increased volatility. SpaceX is valued at approximately $2 trillion for the potential offering and is uniquely positioned to dominate space-based data center and AI infrastructure due to its existing satellite constellation. The S&P 500 is considering reducing the seasoning requirement from 12 months to 6 months for index inclusion to accommodate large IPOs, though this creates valuation challenges as newly public companies must transition from VC-pleasing to shareholder-profit models while facing higher interest rate environments. Tesla is trading as a proxy for SpaceX investment ahead of the IPO, which explains Tesla's outperformance despite broader tech weakness.

Consumer bifurcation persists: spending strong despite record-low sentiment

Consumer sentiment hit record lows with 63% of KPMG survey respondents expecting a recession within the next year, yet retail spending remains resilient with 60% planning summer travel and nearly 90% planning to drive for Memorial Day weekend. The K-shaped economy persists: lower-income earners are sensitive to gas prices above the $4.50 threshold and are shifting to closer-to-home, shorter trips around specific events like weddings, while affluent consumers continue discretionary spending on experiences and premium goods. Stu Leonard Jr., CEO of Stu Leonard's grocery chain, confirmed meat prices up 2.5-3% for Memorial Day with ribeye steaks at $70-80 per pound, but noted consumers trading down to pork chops under $10 and chicken at $5 per pound. Herd sizes are at 50-year lows while demand remains high, explaining the increase. Leonard explained the supply-chain squeeze: an extra $2,000 transportation cost from Florida to New York for tomato trucks forces farmers and retailers to split costs with customers, as he refuses to raise prices despite absorbing inflation for a year. He expects to sell 30,000 lobster rolls at $12.99 this summer, compared to $20-40 elsewhere. Nearly 6 in 10 Americans say they don't know how long their retirement savings will last, signaling anxiety despite continued spending.

Takeaways

  • The market rotation from mega-cap tech to smaller stocks and healthcare is real but fragile—concentration risk remains high, so diversification into software and pharma with genuine innovation makes sense.
  • Watch the PCE inflation number Thursday closely; if headline exceeds the 0.5% forecast, Warsh's growth-friendly tone will be tested and rates could remain higher longer than markets expect.
  • OpenAI and SpaceX IPOs next week could reshape index flows and volatility—Tesla is a leveraged bet on SpaceX upside and worth watching for execution risk on the June 5th options expiration.
  • Pharma's multi-year outperformance cycle is underpriced: Lilly's obesity dominance, $1B in government quantum funding, and M&A activity create genuine secular tailwinds after years of underperformance.

Key moments

0:00Dow hits first record high since February

Yeah, we got all three of the majors in green territory and the Dow closing at its first record high since February.

3:00Bond yields spike to 20-year highs creating early-week turbulence

30-year bond yields climbed above 5% mark, approaching 2007 highs for the first time in 20 years

10:00Trump swears in Fed chair Warsh with growth-friendly message

I want Kevin to be totally independent. I want him to be independent and just do a great job. Don't look at me. Don't look at anybody. Just do your own thing and do a great job. Stock market's up 600 points. That means they like you.

20:00Eli Lilly demolishes obesity drug market with 28-30% weight loss

Eli Lilly's triple G phase 3 data achieved 28-30% weight loss over two years, substantially exceeding Novo's semaglutide at 15%

30:00OpenAI preparing IPO filing for next week

OpenAI could file for IPO next week according to reports, setting up what could be one of the biggest public debuts ever

Get AI-powered video digests

Follow your favorite creators and get concise summaries delivered to your dashboard. Save hours every week.

Start for free